Crescita Therapeutics Inc. (TSX:CTX)
Canada · Delayed Price · Currency is CAD 0.7600
+0.0100 (1.33%)
May 1, 2026, 2:11 PM EST
Crescita Therapeutics Earnings Call Transcripts
Fiscal Year 2024
-
A fully integrated dermatology company highlighted its diverse product portfolio, strong cash position, and recent acquisition of Aquafolia. Growth strategies focus on expanding commercial reach, securing long-term manufacturing contracts, and finding a new U.S. partner for Pliaglis.